Table 2.
Metabolite [mmol/L] |
Con | AD | FC | p-value | FDR | ||
---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | ||||
Discovery study | |||||||
Valine | 0.118 | 0.019 | 0.092 | 0.011 | − 0.2 | 0.007 | 0.07 |
Histidine | 0.037 | 0.002 | 0.032 | 0.002 | − 0.1 | 0.009 | 0.07 |
Pyruvic acid | 0.032 | 0.007 | 0.026 | 0.004 | − 0.2 | 0.03 | 0.19 |
Validation study | |||||||
Tyrosine | 0.071 | 0.016 | 0.051 | 0.011 | − 0.3 | 0.006 | 0.09 |
Valine | 0.275 | 0.052 | 0.214 | 0.040 | − 0.2 | 0.01 | 0.09 |
Pyruvic acid | 0.118 | 0.031 | 0.079 | 0.027 | − 0.3 | 0.02 | 0.09 |
Leucine | 0.111 | 0.035 | 0.078 | 0.017 | − 0.3 | 0.02 | 0.09 |
Two metabolites were dysregulated in serum samples between cognitively affected and healthy individuals in both the discovery and validation studies, sorted according to p-value. Abbreviations; AD – Alzheimer’s Disease, Con – Healthy controls, FC – Fold change, SD – Standard deviation